The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
2,688 reports and counting
Zillow transforms real estate industry with $70M IPO at $10B valuation
Zillow achieves $10B valuation through $70M IPO funding, establishing dominance in the real estate market with innovative online real estate marketplace and technology platform.
Compass transforms real estate industry with $370M IPO at $6.4B valuation
Compass achieves $6.4B valuation through $370M IPO funding, establishing dominance in the real estate market with innovative technology-powered real estate brokerage platform.
Opendoor transforms real estate industry with $400M IPO at $18B valuation
Opendoor achieves $18B valuation through $400M IPO funding, establishing dominance in the real estate market with innovative digital platform for buying and selling residential real estate.
WeWork transforms real estate industry with $4.4B Series G at $8B valuation
WeWork achieves $8B valuation through $4.4B Series G funding, establishing dominance in the real estate market with innovative flexible workspace and commercial real estate platform.
Databricks reaches $43B valuation with $500M Series J funding
Databricks raises $500M in Series J funding as enterprises accelerate data and AI initiatives, reaching a $43B valuation.
OpenAI raises $6.6B in Series C funding, reaches $157B valuation
OpenAI closes one of the largest funding rounds in history, raising $6.6 billion to accelerate AI research and expand global operations.
AeroVault raises $600M Series D in September 2025 funding round
AeroVault secures $600M in Series D funding in September 2025, reaching $8.5B valuation to advance its space-based data storage and computing infrastructure platform.
RoboLogistics raises $320M Series C in September 2025 funding round
RoboLogistics secures $320M in Series C funding in September 2025, reaching $3.8B valuation to advance its autonomous warehouse robotics and fulfillment automation.
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.